152 studies found for:    "Idiopathic pulmonary fibrosis"
Show Display Options
Rank Status Study
21 Recruiting Study to Test the Validity of the Treatment of Idiopathic Pulmonary Fibrosis With Cotrimoxazole
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Cotrimoxazole;   Drug: Placebo
22 Completed A Study to Evaluate the Potential Role of Mesenchymal Stem Cells in the Treatment of Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Other: Placental MSC
23 Withdrawn Safety and Tolerability Study of Macitentan in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: Macitentan
24 Unknown  Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafil
Conditions: Pulmonary Arterial Hypertension;   Idiopathic Pulmonary Fibrosis;   Interstitial Lung Disease;   Pulmonary Hypertension
Intervention: Drug: sildenafil
25 Completed Efficacy and Safety of Oral Bosentan in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: bosentan;   Drug: Placebo
26 Completed
Has Results
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: Bosentan
27 Not yet recruiting Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Conditions: Interstitial Lung Disease;   Idiopathic Pulmonary Fibrosis
Intervention:
28 Terminated A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF)
Conditions: Idiopathic Pulmonary Fibrosis;   Pulmonary Fibrosis;   Fibrosis;   Interstitial Lung Disease;   Lung Diseases, Interstitial
Interventions: Drug: CC-930;   Other: Placebo
29 Recruiting Evaluate the Safety and Efficacy of FG-3019 in Patients With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: FG-3019;   Drug: Placebo
30 Terminated
Has Results
ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis
Conditions: Idiopathic Pulmonary Fibrosis;   Pulmonary Hypertension
Interventions: Drug: Ambrisentan;   Drug: Placebo
31 Completed Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
32 Recruiting Idiopathic Pulmonary Fibrosis Registry for Future Studies
Conditions: Lung Disease, Interstitial;   Idiopathic Pulmonary Fibrosis
Intervention:
33 Completed Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Other: Pulmonary rehabilitation
34 Completed Treatment of Idiopathic Pulmonary Fibrosis With Thalidomide
Condition: Idiopathic Pulmonary Fibrosis (IPF)
Intervention: Drug: Thalidomide
35 Terminated
Has Results
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: warfarin;   Drug: placebo
36 Completed Treatment of Idiopathic Pulmonary Fibrosis With Long Acting Octreotide
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: octreotide
37 Unknown  Targeting Vascular Reactivity in Idiopathic Pulmonary Fibrosis
Conditions: Idiopathic Pulmonary Fibrosis;   Pulmonary Fibrosis
Interventions: Drug: Sildenafil;   Drug: Losartan;   Drug: Sildenafil and Losartan;   Drug: Placebo pill
38 Completed Zileuton for the Treatment of Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: zileuton;   Drug: azathioprine/prednisone
39 Recruiting Evaluation of Patients With Idiopathic Pulmonary Fibrosis (IPF) Through an IPF Registry
Condition: Idiopathic Pulmonary Fibrosis
Intervention:
40 Active, not recruiting Long-Term Safety Study of GS-6624 to Treat Idiopathic Pulmonary Fibrosis (IPF)
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: Simtuzumab

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years